[go: up one dir, main page]

FI891362A0 - Menetelmä uusien alkanofenonien valmistamiseksi - Google Patents

Menetelmä uusien alkanofenonien valmistamiseksi

Info

Publication number
FI891362A0
FI891362A0 FI891362A FI891362A FI891362A0 FI 891362 A0 FI891362 A0 FI 891362A0 FI 891362 A FI891362 A FI 891362A FI 891362 A FI891362 A FI 891362A FI 891362 A0 FI891362 A0 FI 891362A0
Authority
FI
Finland
Prior art keywords
optionally
lower alkyl
salt
denotes
obtainable according
Prior art date
Application number
FI891362A
Other languages
English (en)
Swedish (sv)
Other versions
FI94342C (fi
FI94342B (fi
FI891362A (fi
Inventor
Sprecher Andreas Von
Andreas Beck
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI891362A0 publication Critical patent/FI891362A0/fi
Publication of FI891362A publication Critical patent/FI891362A/fi
Application granted granted Critical
Publication of FI94342B publication Critical patent/FI94342B/fi
Publication of FI94342C publication Critical patent/FI94342C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI891362A 1988-03-29 1989-03-22 Menetelmä uusien alkanofenonien valmistamiseksi FI94342C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH118688 1988-03-29
CH118688 1988-03-29
CH385788 1988-10-14
CH385788 1988-10-14

Publications (4)

Publication Number Publication Date
FI891362A0 true FI891362A0 (fi) 1989-03-22
FI891362A FI891362A (fi) 1989-09-30
FI94342B FI94342B (fi) 1995-05-15
FI94342C FI94342C (fi) 1995-08-25

Family

ID=25686932

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891362A FI94342C (fi) 1988-03-29 1989-03-22 Menetelmä uusien alkanofenonien valmistamiseksi

Country Status (19)

Country Link
EP (1) EP0335315B1 (fi)
JP (1) JP2777183B2 (fi)
KR (1) KR0125933B1 (fi)
AT (1) ATE107639T1 (fi)
AU (1) AU623383B2 (fi)
CA (1) CA1340463C (fi)
CY (1) CY1967A (fi)
DE (1) DE58907920D1 (fi)
DK (1) DK148989A (fi)
ES (1) ES2056137T3 (fi)
FI (1) FI94342C (fi)
HK (1) HK192696A (fi)
HU (2) HU202852B (fi)
IE (1) IE66248B1 (fi)
IL (1) IL89713A0 (fi)
NO (1) NO171555C (fi)
NZ (1) NZ228477A (fi)
PT (1) PT90125B (fi)
YU (1) YU63089A (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
EP0419411A3 (en) * 1989-09-19 1991-09-04 Ciba-Geigy Ag Additional alkanophenones
US6596260B1 (en) * 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
ATE258813T1 (de) 1995-04-14 2004-02-15 Smithkline Beecham Corp Vorrichtung zur dosierten inhalierung von beclomethason-diproprionat
DK0820322T3 (da) 1995-04-14 2002-10-07 Smithkline Beecham Corp Dosisudmålende inhalator til Fluticason Propionat
DK0820323T3 (da) 1995-04-14 2003-11-24 Smithkline Beecham Corp Inhalator til afmålte doser af salmeterol
SK281746B6 (sk) 1995-04-14 2001-07-10 Glaxo Wellcome Inc. Merací dávkovací inhalátor, neplnený merací dávkovací inhalátor a merací dávkovací inhalačný systém
IT1320162B1 (it) 2000-02-09 2003-11-18 Rotta Research Lab Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
ATE358672T1 (de) 2000-10-23 2007-04-15 Arizona Biomedical Res Commiss Antitumor verbindungen basierend auf der regulierung von protein prenylation
EP2565178A1 (en) 2002-10-03 2013-03-06 Ono Pharmaceutical Co., Ltd. LPA Receptor Antagonists
JP4766384B2 (ja) * 2003-12-19 2011-09-07 小野薬品工業株式会社 リゾホスファチジン酸受容体拮抗作用を有する化合物およびその用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070912D1 (en) * 1979-03-20 1985-09-05 Fisons Plc Pharmaceutical heterocyclic compounds, processes for their preparation and compositions containing them
ATE25251T1 (de) * 1981-11-12 1987-02-15 Fisons Plc Anti srs-a carbonsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische formulierungen.
AU548450B2 (en) * 1983-08-08 1985-12-12 G.D. Searle & Co. Substituted dihydrobenzopyrans
CA1288107C (en) * 1983-12-27 1991-08-27 Yves Girard Leukotriene antagonists
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
US4546194A (en) * 1984-05-29 1985-10-08 G. D. Searle & Co. Substituted chromanon-2-yl alkanols and derivatives thereof
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
EP0419411A3 (en) * 1989-09-19 1991-09-04 Ciba-Geigy Ag Additional alkanophenones

Also Published As

Publication number Publication date
DE58907920D1 (de) 1994-07-28
IL89713A0 (en) 1989-09-28
AU3225289A (en) 1989-10-12
KR890014511A (ko) 1989-10-24
HUT49599A (en) 1989-10-30
NO891286D0 (no) 1989-03-28
KR0125933B1 (ko) 1997-12-26
IE66248B1 (en) 1995-12-27
FI94342C (fi) 1995-08-25
JPH01299283A (ja) 1989-12-04
DK148989A (da) 1989-09-30
NO171555C (no) 1993-03-31
HU210531A9 (en) 1995-04-28
AU623383B2 (en) 1992-05-14
ATE107639T1 (de) 1994-07-15
IE890935L (en) 1989-09-29
DK148989D0 (da) 1989-03-28
HU202852B (en) 1991-04-29
ES2056137T3 (es) 1994-10-01
HK192696A (en) 1996-10-25
EP0335315B1 (de) 1994-06-22
FI94342B (fi) 1995-05-15
NO891286L (no) 1989-10-02
JP2777183B2 (ja) 1998-07-16
NZ228477A (en) 1990-11-27
NO171555B (no) 1992-12-21
PT90125A (pt) 1989-11-10
PT90125B (pt) 1994-10-31
CA1340463C (en) 1999-03-23
CY1967A (en) 1997-07-04
EP0335315A1 (de) 1989-10-04
YU63089A (en) 1990-12-31
FI891362A (fi) 1989-09-30

Similar Documents

Publication Publication Date Title
KR900006318A (ko) 피페리디닐 벤즈이미다졸
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
KR870001142A (ko) 페닐 에테르의 제법
ES2056137T3 (es) Nuevas alcanofenonas.
KR910020006A (ko) 옥사졸리디논
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
KR890001965A (ko) 스퍼구알린 관련 유도체
SE8100846L (sv) Antirinovirusmedel
FI832582A (fi) Foerfarande foer framstaellning av nya tieno-tiazol-derivat och dessa foereningar innehaollande laekemedel
KR900003118A (ko) 술폰아미도시클로알칸화합물, 이것의 제조방법 및 이것을 함유하는 제약조성물
PT90840A (pt) Processo para a preparcao de 3-aminosidnoniminas substituidas e de composicoes farmaceuticas que as contem
IL87796A0 (en) Substituted 3-aminosydnonimines,their preparation and pharmaceutical compositions containing them
GB2111056A (en) Derivatives of 1, 4-thiazane-carboxylic acid preparation and utilization thereof and compositions containing same
KR930005953A (ko) 리그난, 이의 중간체 및 이러한 중간체의 제조방법
KR890009903A (ko) 뇌부전증 개선제로서 유효한 신규 화합물
ES2036561T3 (es) Un procedimiento para preparar un grupo de compuestos que son acidos 4-hidroxi-4-(alquenil sustituido)ciclohexanocarboxilicos.
KR830002745A (ko) 피페라진 유도체의 제법

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed

Owner name: NOVARTIS AG